Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ycellbio Medical is a South Korean medical device company focused on cell regeneration therapy and platelet-rich plasma preparation systems. The company manufactures and markets PRP blood separation kits, related consumables, and centrifuges used at the point of care for regenerative and aesthetic procedures. Its core commercial offering is the Y-PRP SYSTEM, which is designed to isolate highly concentrated PRP quickly from a patient blood sample. Ycellbio states that it has led the domestic PRP market in South Korea and distributes products internationally, including through a U.S. commercial presence. The company appears to be a commercial-stage medical device manufacturer rather than a therapeutics developer, so it does not have a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ycellbio Medical.